SANTINI, VALERIA

SANTINI, VALERIA  

Medicina Sperimentale e Clinica  

Mostra records
Risultati 1 - 20 di 236 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
5-Azacytidine for the Treatment of Acute Myeloid Leukemia: A Retrospective, Multicenter Study of 55 Patients. 2008 Luca Maurillo; Alessandra Spagnoli; Mariella Genuardi; Monia Lunghi; Nicola Di Renzo; Alfonso Maria D’Arco; Giuseppe Mele; Alessandro Levis; Antonella Gozzini; Mario Petrini; Manuela Mianulli; Grazia Sanpaolo; Alberto Santagostino; Giuseppe Pietrantuono; Fiorella D’Auria; Dario Ferrero; Gianluca Gaidano; Felicetto Ferrara; Adriano Venditti; Giuseppe Leone; Valeria Santini; and Pellegrino Musto
5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program 2008 Pellegrino Musto; Luca Maurillo; Alessandra Spagnoli; Antonella Gozzini; Flavia Rivellini; Caterina Tatarelli; Monia Lunghi; Carla Fili; Enrico Orciuolo; Lucia Ciuffreda; Ernesto Vigna; Paola Della Cioppa; Anna Candoni; Dario Ferrero; Salvatore Palmieri; Giuseppe Palumbo; Nicola Di Renzo; Esther Oliva; Grazia Sanpaolo; Domenico Pastore; Anna Tonso; Alberto Santagostino; Stefano Rocco; Oreste Villani; Fiorella D’Auria; Alfonso Maria D’Arco; Gianluca Gaidano; Sara Galimberti; Domenico Russo; Adriano Venditti; Maria Antonietta Aloe-Spiriti; Giuseppe Leone; and Valeria Santini
5-Azacytidine, Valproic Acid and ALL-Trans Retinoic Acid in INT-2/High Risk Myelodysplastic Syndromes: Results of the GIMEMA MDS0205 Multicenter TrialBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 3648. 2008 Maria Teresa Voso; Valeria Santini; Carlo Finelli; Lorenza Borin; Emanuele Angelucci; Giuseppe Fioritoni; Benedetta Neri; Agostino Cortellezi; Oreste Villani; Francesco Buccisano; Giovanni Martinelli; Maria Concetta Petti; Gina Zini; Alfonso Piciocchi; Paola Fazi; Giuliana Alimena; Marco Gobbi; Vincenzo Liso; and Giuseppe Leone
A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells. 1989 Dal Pozzo O;Bernabei PA;Santini V;Saccardi R;Santini S;Rossi Ferrini P
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes 2014 Alhan, Canan; Westers, Theresia M.; van der Helm, Lieke H.; Eeltink, Corien; Huls, Gerwin; Witte, Birgit I.; Buchi, Francesca; Santini, Valeria; Ossenkoppele, Gert J.; van de Loosdrecht, Arjan A.
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 2002 A. Gozzini; E. Rovida; A Pratesi; P. Dello Sbarba; P Rossi Ferrini; V. Santini
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 2011 Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. 2011 Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels 2020 Santini V.; Almeida A.; Giagounidis A.; Skikne B.; Beach C.L.; Weaver J.; Tu N.; Fenaux P.
Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro. 1999 Bernabei PA;Landini I;Bartolozzi B;Banchelli I;Degli Innocenti o Nocentini A;Santini V;Ematologia UO
Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. 1991 TOUW I; DONATH J; POUWELS K; VAN BUITENEN C; SCHIPPER P; V. SANTINI; HAGEMEIJER A; LOWENBERG B; DELWEL R.
Advances in myelodysplastic syndrome. 2021 Valeria Santini
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study 2018 Stahl M.; DeVeaux M.; Montesinos P.; Itzykson R.; Ritchie E.K.; Sekeres M.A.; Majhail N.; Barnard J.; Podoltsev N.A.; Brunner A.M.; Komrokji R.S.; Bhatt V.R.; Al-Kali A.; Cluzeau T.; Santini V.; Roboz G.J.; Fenaux P.; Litzow M.; Fathi A.T.; Perreault S.; Kim T.K.; Prebet T.; Vey N.; Verma V.; Kobbe G.; Bergua J.; Serrano J.; Gore S.D.; Zeidan A.M.
Amifostine in the treatment of low-risk myelodysplastic syndromes. 2000 GROSSI A; FABBRI A; V. SANTINI; LEONI F; NOZZOLI C; LONGO G; PAGLIAI G; CIOLLI S; ROSSI FERRINI P.
Amifostine: chemotherapeutic and radiotherapeutic protective effects 2001 V.Santini
Anemia as the Main Manifestation of Myelodysplastic Syndromes 2015 Santini, Valeria
Anemie 2003 V. Santini; G.Longo
Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders. 1997 Santini V;Bernabei A;Gozzini A;Scappini B;Zoccolante A;D'Ippolito G;Figuccia M;Ferrini PR
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 2016 Kosmider, Olivier; Passet, Marie; Santini, Valeria; Platzbecker, Uwe; Andrieu, Valérie; Zini, Gina; Beyne-Rauzy, Odile; Guerci, Agnès; Masala, Erico; Balleari, Enrico; Bulycheva, Ekaterina; Dreyfus, François; Fenaux, Pierre; Fontenay, Michaela; Park, Sophie
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study 2018 Basiorka A.A.; McGraw K.L.; Abbas-Aghababazadeh F.; McLemore A.F.; Vincelette N.D.; Ward G.A.; Eksioglu E.A.; Sallman D.A.; Ali N.A.; Padron E.; Pinilla-Ibarz J.; Komrokji R.; Masala E.; Santini V.; Kosmider O.; Fontenay M.; Fenaux P.; Sokol L.; Wei S.; Fridley B.; List A.F.